Schedule 13D ownership disclosure

Rocket Pharmaceuticals Inc

Security class unavailable · CUSIP: 77313F106

Event date: 2022-10-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
24.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-22-004506
Form type
SC 13D/A
Filer
ROCKET PHARMACEUTICALS, INC.
CIK
CIK 1281895
Filed
Oct 11, 2022
Reporting period
Oct 06, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub